ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF
The disclosure provides antibody molecules that bind to TCR Vβ regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, pharmaceutical compositions comprising aforesaid molecules...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
02.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The disclosure provides antibody molecules that bind to TCR Vβ regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecules, pharmaceutical compositions comprising aforesaid molecules, and methods of treating a cancer using the aforesaid molecules. |
---|---|
Bibliography: | Application Number: US202217820806 |